Dr. Pavel Osmancik and Dr. C. Michael Gibson Discuss: PRAGUE-17: Three-Year Outcomes From a Randomized Trial of Left Atrial Appendage Closure Versus Direct Acting Oral Anticoagulation in Patients With Atrial Fibrillation November 5, 2021 Disclosures: TBA
Dr. DJ Lakkireddy and Dr. C. Michael Gibson Discuss: AMULET IDE: One-Year Device Closure and Device-Related Thrombus Outcomes From a Randomized Trial of Amulet versus Watchman for Left Atrial Appendage Occlusion November 5, 2021 Disclosures: TBA
Dr. David J. Cohen and Dr. C. Michael Gibson Discuss: PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk November 5, 2021 Disclosures: TBD
Dr. Nicolas Van Mieghem and Dr. Yaz Dabboul Discuss: SURTAVI: Five-Year Results From a Randomized Trial of TAVR vs. SAVR in Patients at Intermediate Surgical Risk November 5, 2021 Disclosures: TBD
Dr. Roxana Mehran and Dr. C. Michael Gibson Discuss: TCT 2021 Daily Wrap-Up – November 4, 2021 November 4, 2021 Disclosures: TBA
Dr. Ajay Kirtane and Dr. Yazan Daaboul: RADIANCE-HTN: Six-Month Outcomes of a Randomized Trial of Renal Denervation Versus a Sham Procedure for Resistant Hypertension – Impact of Treatment-Blinded Medication Titration November 4, 2021 Disclosures: TBA
Dr. Rafael Romaguera and Dr. C. Michael Gibson Discuss: SUGAR: A Randomized Trial of Amphilimus-eluting Stents and Zotarolimus-eluting Stents in Patients With Diabetes November 4, 2021 Disclosures: TBA
Dr. Bo Xu and Dr. C. Michael Gibson Discuss: FAVOR III China: A Sham-Controlled Randomized Trial Comparing QFR-Guided and Angiography-Guided PCI November 4, 2021 Disclosures: TBA
Dr. William Fearon and Dr. C. Michael Gibson Discuss: FAME 3: A Randomized Trial of FFR-Guided Stenting Compared With CABG November 4, 2021 Disclosures: TBA
Dr. David E. Kandzari and Dr. C. Michael Gibson Discuss: OPTIMUM: Early Outcomes From a Prospective Registry of PCI in Patients at Prohibitive Risk for CABG November 4, 2021 Disclosures: TBA
